- Degree
- Bachelor of Science
- Course location
- Bremen
- Teaching language
- • English
- Languages
- Language of instruction: English
Language courses are available in German.
- Full-time / part-time
- • full-time
- Programme duration
- 6 semesters
- Beginning
- Winter semester
- Application deadline
- To be considered for admission to an undergraduate programme, you need to apply by the following deadlines:
• Early decision: application due by 1 November
• Early action I: application due by 1 December
• Early action II: application due by 1 February
Rolling admission:
• Application due by 1 June for international students (who require a visa to enter and study in Germany)
• Application due by 31 July for EU/EEA citizens and citizens who do not require a visa
For more information, please check our website: https://constructor.university/admission-aid/application-information-undergraduate (https://constructor.university/admission-aid/application-information-undergraduate?utm_source=DAAD&utm_medium=Profile&utm_content=medicinal_chemistry_chemical_biology)
- Tuition fees per semester in EUR
- 10,000 EUR
- Additional information on tuition fees
- Annual undergraduate 2025/26 tuition fees: 20,000 EUR
Annual graduate 2025/26 tuition fees: 20,000 EUR
Annual International Foundation Year 2025/26 tuition fees: 12,000 EUR
Annual online programme 2025/26 tuition fees: 5,000 EUR
- Joint degree / double degree programme
- No
- Description/content
- The global pharmaceutical sector depends on highly educated and ambitious scientists dedicated to pioneering new drug developments. The Medicinal Chemistry and Chemical Biology (MCCB) programme positions students at the leading edge of these initiatives by delivering a deep understanding of how drugs interact with the body, from molecular to physiological levels. This comprehensive approach not only focuses on disease treatment (medicinal chemistry) but also highlights the importance of understanding cellular pathways (chemical biology), paving the way for ground-breaking approaches to disease treatment. The MCCB programme stands out in Germany's academic field, and it aims to meet the dynamic demands of the rapidly-expanding pharmaceutical industry.